PRIORITY-T2D Trademark

Trademark Overview

On Thursday, February 23, 2023, a trademark application was filed for PRIORITY-T2D with the United States Patent and Trademark Office. The USPTO has given the PRIORITY-T2D trademark a serial number of 97808913. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, January 16, 2026. This trademark is owned by Eli Lilly and Company. The PRIORITY-T2D trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of diabetes
priority-t2d

General Information

Serial Number97808913
Word MarkPRIORITY-T2D
Filing DateThursday, February 23, 2023
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, January 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements

Pseudo MarkPRIORITY T TWO D
Goods and ServicesMedical and scientific research in the field of diabetes

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 14, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, February 27, 2023NEW APPLICATION ENTERED
Tuesday, March 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 16, 2023ASSIGNED TO EXAMINER
Thursday, November 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 1 FILED
Tuesday, July 23, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 9, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 9, 2025SOU EXTENSION 2 FILED
Thursday, January 9, 2025SOU EXTENSION 2 GRANTED
Thursday, January 9, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 10, 2025SOU TEAS EXTENSION RECEIVED
Thursday, July 10, 2025SOU EXTENSION 3 FILED
Thursday, July 10, 2025SOU EXTENSION 3 GRANTED
Friday, July 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 16, 2026SOU TEAS EXTENSION RECEIVED
Friday, January 16, 2026SOU EXTENSION 4 FILED
Friday, January 16, 2026SOU EXTENSION 4 GRANTED
Saturday, January 17, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

priority diabetes field research scientific medical